Annual Conference 2014

261 - Evaluation and Management of Bladder Cancer

Nov 2, 2014 3:45pm ‐ Nov 2, 2014 4:45pm

Standard: $20.00
Members: $0.00

Description

Etiologic factors implicated in bladder cancer, outline laboratory and radiologic studies, and cystoscopic techniques utilized in the diagnosis of bladder cancer are discussed in this session. Current trends in the treatment of bladder cancer, including pharmacologic treatments, endoscopic techniques and surgical interventions are also presented.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
• Name 3 etiologic factors associated with bladder cancer.
• Describe laboratory and imaging studies used in the evaluation of bladder cancer.
• List options of pharmaceutical and surgical management of bladder cancer.

Speaker(s):

You must be logged in and own this session in order to post comments.